REVIEW ARTICLE
Refractory angina pectoris
Mechanism and therapeutic options
Michael C. Kim, MDa,
Annapoorna Kini, MDa and
Samin K. Sharma, MD, FACCa,*
a Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York, USA
Manuscript received October 11, 2001;
revised manuscript received December 26, 2001,
accepted January 2, 2002.
* Reprint requests and correspondence: Dr. Samin K. Sharma, Mount Sinai Medical Center, P.O. Box 1030, One Gustave L. Levy Place, New York, New York 10029, USA.
samin.sharma{at}msnyuhealth.org
As the survival of patients with primary coronary events continues to increase, the number of patients presenting with coronary artery disease unsuitable to further revascularization techniques and symptoms refractory to medical therapy also continues to rise. The aims of this review were to define the population of patients with refractory angina pectoris and to present the therapeutic options currently available for this condition. Refractory angina pectoris is defined, and traditional medical therapies are discussed. Then, current therapeutic options for patients with refractory angina are extensively reviewed. A multitude of therapeutic options exist for patients with refractory angina pectoris. Small, uncontrolled studies have shown a potential benefit for additional antiplatelet and antithrombotic therapy. In randomized trials, neurostimulation has been shown to be effective in reducing angina symptoms. Enhanced external counterpulsation is a viable treatment option for select patients with refractory angina. In many randomized trials, laser revascularization has been shown to diminish angina symptoms, although no placebo-controlled studies exist to date. Gene therapy is a promising area of research in this field. Percutaneous in situ coronary venous arterialization is in its infancy, but may be able to treat many patients if proved successful. No data support the role of chelation therapy in this population. Heart transplantation remains a final option for these patients. Further research of the techniques mentioned in this review is warranted. The importance of randomized, double-blinded, placebo-controlled trials cannot be overemphasized, as the placebo effect of these therapies is probably marked.
|
Abbreviations and Acronyms
| | PTMLR | | ACE | | angiotensin-converting enzyme | | bFGF | | basic fibroblast growth factor | | CABG | | coronary artery bypass graft surgery | | CAD | | coronary artery disease | | CCS | | Canadian Cardiovascular Society | | EDTA | | ethylenediamine-tetraacetic acid | | EECP | | enhanced external counterpulsation | | EMM | | electromechanical mapping | | LAD | | left anterior descending coronary artery | | LDL | | low-density lipoprotein | | LMWH | | low-molecular-weight heparin | | PCI | | percutaneous coronary intervention | | PICAB | | percutaneous in situ coronary venous arterialization | | PICVA | | percutaneous in situ coronary venous arterialization | | PTMLR | | percutaneous transmyocardial laser revascularization | | rFGF | | recombinant fibroblast growth factor | | SCS | | spinal cord stimulation | | SPECT | | single-photon emission computed tomography | | TENS | | transcutaneous electrical nerve stimulation | | TMLR | | transmyocardial laser revascularization | | VEGF | | vascular-endothelial growth factor |
|
This article has been cited by other articles:
|
|
|
|
 
M. Huang, D. A. Chan, F. Jia, X. Xie, Z. Li, G. Hoyt, R. C. Robbins, X. Chen, A. J. Giaccia, and J. C. Wu
Short Hairpin RNA Interference Therapy for Ischemic Heart Disease
Circulation,
September 30, 2008;
118(14_suppl_1):
S226 - S233.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Manchanda and O. Soran
Enhanced External Counterpulsation and Future Directions: Step Beyond Medical Management for Patients With Angina and Heart Failure
J. Am. Coll. Cardiol.,
October 16, 2007;
50(16):
1523 - 1531.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Ben-Dor and A. Battler
Treatment of stable angina
Heart,
July 1, 2007;
93(7):
868 - 874.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Abbate, G. G.L. Biondi-Zoccai, P. Agostoni, M. J. Lipinski, and G. W. Vetrovec
Recurrent angina after coronary revascularization: a clinical challenge
Eur. Heart J.,
May 1, 2007;
28(9):
1057 - 1065.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Lapenna, D. Rapati, P. Cardano, M. De Bonis, F. Lullo, A. Zangrillo, and O. Alfieri
Spinal Cord Stimulation for Patients With Refractory Angina and Previous Coronary Surgery
Ann. Thorac. Surg.,
November 1, 2006;
82(5):
1704 - 1708.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Stritesky, M. Dobias, R. Demes, M. Semrad, E. Poliachova, T. Cermak, J. Charvat, and I. Malek
Endoscopic thoracic sympathectomy - its effect in the treatment of refractory angina pectoris
Interactive CardioVascular and Thoracic Surgery,
August 1, 2006;
5(4):
464 - 468.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Authors/Task Force Members, K. Fox, M. A. A. Garcia, D. Ardissino, P. Buszman, P. G. Camici, F. Crea, C. Daly, G. De Backer, P. Hjemdahl, et al.
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology
Eur. Heart J.,
June 1, 2006;
27(11):
1341 - 1381.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Hua, J. L. Ardell, and C. A. Williams
Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia
Am J Physiol Regulatory Integrative Comp Physiol,
December 1, 2004;
287(6):
R1468 - R1477.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Tio, E. S. Tan, G. A.J. Jessurun, N. Veeger, P. L. Jager, R. H.J.A. Slart, R. M. de Jong, J. Pruim, G. A.P. Hospers, A. T.M. Willemsen, et al.
PET for Evaluation of Differential Myocardial Perfusion Dynamics After VEGF Gene Therapy and Laser Therapy in End-Stage Coronary Artery Disease
J. Nucl. Med.,
September 1, 2004;
45(9):
1437 - 1443.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Svorkdal
Treatment of Inoperable Coronary Disease and Refractory Angina: Spinal Stimulators, Epidurals, Gene Therapy, Transmyocardial Laser, and Counterpulsation
Seminars in Cardiothoracic and Vascular Anesthesia,
March 1, 2004;
8(1):
43 - 58.
[Abstract]
[PDF]
|
|
|
|
|
|
|
U. Thadani
Current Medical Management of Chronic Stable Angina
Journal of Cardiovascular Pharmacology and Therapeutics,
March 1, 2004;
9(1_suppl):
S11 - S29.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B. R. Chaitman
Efficacy and Safety of a Metabolic Modulator Drug in Chronic Stable Angina: Review of Evidence from Clinical Trials
Journal of Cardiovascular Pharmacology and Therapeutics,
March 1, 2004;
9(1_suppl):
S47 - S64.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Shechter, S. Matetzky, M. S. Feinberg, P. Chouraqui, Z. Rotstein, and H. Hod
External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris
J. Am. Coll. Cardiol.,
December 17, 2003;
42(12):
2090 - 2095.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R M Sinvhal, R M Gowda, and I A Khan
Enhanced external counterpulsation for refractory angina pectoris
Heart,
August 1, 2003;
89(8):
830 - 833.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. O. Bonetti, D. R. Holmes Jr, A. Lerman, and G. W. Barsness
Enhanced external counterpulsation for ischemic heart disease: What's behind the curtain?
J. Am. Coll. Cardiol.,
June 4, 2003;
41(11):
1918 - 1925.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. O'Toole and E. D Grech
Chronic stable angina: treatment options
BMJ,
May 29, 2003;
326(7400):
1185 - 1188.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. O. Bonetti, G. W. Barsness, P. C. Keelan, T. I. Schnell, G. M. Pumper, J. T. Kuvin, R. P. Schnall, D. R. Holmes Jr, S. T. Higano, and A. Lerman
Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease
J. Am. Coll. Cardiol.,
May 21, 2003;
41(10):
1761 - 1768.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. L. DeJongste, R. W. M. Hautvast, and R. A. Tio
Therapeutic options for patients with chronic refractory angina pectoris
J. Am. Coll. Cardiol.,
October 16, 2002;
40(8):
1541 - 1541.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. C. Kim, A. S. Kini, and S. K. Sharma
Therapeutic options for patients with chronic refractory angina pectoris: Reply
J. Am. Coll. Cardiol.,
October 16, 2002;
40(8):
1541 - 1542.
[Full Text]
[PDF]
|
|
|
|
